Each the European Medicines Company and the UK’s Medicines and Healthcare merchandise Regulatory Company have concluded there’s a doable hyperlink between the AstraZeneca vaccine and uncommon types of blood clotting. Nonetheless, the responses of various nations to those findings have different considerably.
Denmark has withdrawn the vaccine completely. In Germany the vaccine is barely being given to over-60s, whereas France has determined that under-55s ought to get totally different COVID vaccine for his or her second dose. However within the UK, authorities haven’t mandated any motion, saying solely that it could be preferential to supply under-30s an alternate vaccine the place doable.
These are considerably totally different positions, so how can we make sense of them? How dangerous is the vaccine? Sadly, reaching a particular conclusion is troublesome, and this maybe explains a few of this variation between nations. Right here’s why it’s so difficult.
Two particular clotting problems have been linked to the AstraZeneca vaccine: cerebral venous sinus thrombosis (CVST), the place clots kind within the veins that drain blood from the mind, and splanchnic vein thrombosis (SVT), the place clots kind within the belly veins. They’ve coincided with folks having low platelet counts (thrombocytopenia), with CVST showing extra continuously.
To find out the chance posed by the vaccine, the important thing query is: are a better share of individuals growing these uncommon clots after receiving the vaccine than would achieve this usually? Right here’s what’s identified up to now.
As of April 4, 34 million AstraZeneca doses had been given in Europe, with 169 CVST and 53 SVT circumstances reported. Within the UK as much as the top of March, 20 million doses had been given, with 54 CVST and 25 SVT circumstances. Put collectively, this equals round one case of CVST per 240,000 doses and one in all SVT per 690,000 doses.
A generally quoted estimate for the background incidence of CVST is round one case per 200,000 folks per yr. Given the speed of CVST post-vaccination is greater than this, and rollout has solely been going a few months, this does counsel a raised danger of clotting.
To place this in context, if each particular person in, say, Eire (inhabitants 5 million) was to obtain the vaccine, we’d count on round 21 circumstances of CVST to happen. These would in all probability be on high of the 25 circumstances we’d count on to happen annually anyway, with out vaccination. So the general danger could be very small.
Nonetheless, there are main limitations to evaluating estimates like this.
First, CVST occurring post-vaccination seems to coincide particularly with a low platelet depend. This can be a novel phenomenon and has been given a particular identify: vaccine-induced immune thrombotic thrombocytopenia. Often, CVST isn’t related to immune-driven thrombocytopenia. Because of this, it won’t be acceptable to check CVST that follows vaccination with that which occurs in any other case – they could possibly be fairly totally different situations.
Additionally, CVST is uncommon, which makes background estimates intrinsically unsure. Though the background price above is referred to so much, others exist, and a few are significantly greater. The incidence of CVST can even differ with age, intercourse and different danger elements. For instance, the oral contraceptive tablet has been related with a sevenfold enhance within the danger of CVST in ladies aged 15-50.
This can be notably related as a result of the AstraZeneca vaccine has been disproportionately given to youthful feminine populations in some nations. In Germany, as an example, the vaccine was supplied to medical employees and academics, who are usually feminine. A part of the CVST danger noticed with the vaccine may be attributable to a larger underlying danger in these receiving it.
One other potential situation is that COVID-19 itself has additionally been linked to elevated dangers of each clotting and low platelets (certainly early analysis, awaiting assessment by different scientists, suggests the chance of getting CVST after COVID-19 could possibly be eight to 10 instances what it’s after vaccination). So the pandemic could also be rising the baseline danger for these uncommon blood clots too.
It’s additionally doable that the vaccine may set off CVST in sufferers who’ve an underlying predisposition to growing the situation, which means that some circumstances come up after vaccination in sufferers who would have developed the situation anyway. All these elements make assessments of the vaccine’s danger unsure.
So what to do?
Within the meantime, a practical method could possibly be to check the potential danger of those uncommon clots with the chance posed by COVID-19.
All of the authorized vaccines, together with the AstraZeneca vaccine, present wonderful safety from extreme and deadly COVID-19. The danger of extreme COVID-19 is decrease within the younger, and likewise falls for everybody when the quantity of virus circulating within the inhabitants is decrease. But regardless of this, the UK authorities calculates that the risk-benefit ratio nonetheless favours taking the AstraZeneca vaccine in nearly all circumstances. Solely when the chance of publicity to the virus is low does it turn out to be helpful for under-30s to not take it.
It’s value remembering, too, that among the many younger, COVID-19 can nonetheless kill. Within the UK, it’s estimated that one in each 2,500 folks aged 25-44 who get COVID-19 will die – which is 400 instances the fatality price attributed to vaccine-related blood clots in Britain. Should you’re at larger danger of catching the virus, maybe due to your job, then taking the vaccine is smart.
Word, too, that different COVID-19 vaccines can also carry dangers, which could emerge solely after wider use. For instance, anaphylaxis has been reported after one in each 90,000 Pfizer vaccine doses, and the Johnson & Johnson vaccine can also trigger blood clots.
If the hyperlink between clotting occasions and these vaccines is confirmed, and this danger is proven to be primarily in particular teams, then the usage of alternate options in at-risk teams could be acceptable. Within the meantime, do not forget that no resolution is danger free, and that not taking a COVID-19 vaccine additionally represents a danger.